期刊文献+

激素在慢性阻塞性肺疾病急性加重期的应用 被引量:1

Corticosteroids Therapy for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 在慢性阻塞性肺疾病急性加重期中,激素治疗是一个很普遍的治疗方案。很多研究表明,激素可以缩短康复时间、改进肺功能,并降低早期复发的风险、减少治疗失败的概率和缩短住院时间。该治疗方案在一定程度上存有争议,因为激素治疗存在严重的不良反应,且各种随机对照临床试验就其剂量、疗程和给药方式的研究结果也不尽相同。最佳的初始治疗为低剂量,疗程不超过2周,但具体剂量和天数未明;雾化吸入可作为全身给药的替代疗法,但远期疗效需进一步研究。 The corticosteroids therapy for patients with exacerbation of chronic obstruction pulmonary disease (COPD) has become common practice.A number of studies have indicated that corticosteroids in COPD exacerbations can shorten the recovery time,improve the lung function,and reduce the risk of early relapse,treatment failure,and the length of hospital stay.However,this practice remains controversial due to the serious adverse effects,besides,various studies of randomized clinical trials show different results about dose,duration and mode of administration.The optimal stating dose of corticosteroids is low dose,and the duration should not be longer than two weeks,but the specific dose and days are still unclear.Although nebulized corticosteroids may be an ahernative to systemic treatment,future studies should be done to evaluate the longterm impact.
出处 《医学综述》 2014年第14期2572-2574,共3页 Medical Recapitulate
关键词 激素 剂量 疗程 给药方式 Corticosteroids Dose Treatment course Administration route
  • 相关文献

参考文献21

  • 1Murray C J, Lopez AD. Alternative projections of mortality and disa-bility by cause 1990-2020 : Global Burden of Disease Study [ J ]. Lancet, 1997,349 ( 9064 ) : 1498-1504.
  • 2Vestbo J, Hurd SS, Rodriguez-Roisin R, et al. [ An overview of Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Pulmonary Disease (GOLD) ( revised 2011 ) ] [ J]. Zhonghua Yi Xue Za Zhi,2012,92(14) ,937-938.
  • 3Donaldson GC, Seemungal TA, Bhowmik A, et al. Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease [ J ]. Thorax,2002,57 (10) : 847-852.
  • 4Connors AF Jr, Dawson NV, Thomas C, et al. Outcomes following acute exacerbation of severe chronic obstructive lung disease. The supportinvestigators (Study to Understand Prognoses and Prefer- ences for Outcomes and Risks of Treatments) [ J]. Am J Respir Crit Care Med,1996,154(4 Pt 1 ) :959-967.
  • 5Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagno- sis, management, and prevention of chronic obstructive pulmonary disease : GOLD executive summary [ J ]. Am J Respir Critical Care Med.2013.187(4) :347-365.
  • 6National Collaborating Centre for Chronic Conditions. Chronic obstructive pulmonary disease. National clinical guideline on man- agement of chronic obstructive pulmonary disease in adults in primary and secondary care[J]. Thorax,2004,59 Suppl 1:1-232.
  • 7Celli BR,MacNee W. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J]. Eur Respir J,2004,23(6) :932-946.
  • 8Manser R, Reid D, Abramson M. Corticosteroids for acute severe asthma in hospitalised patients [ J ]. Cochrane Database Syst Rev, 2001,1 : CD001740.
  • 9Vondracek SF,Hemstreet BA. Retrospective evaluation of systemic corticosteroids for the management of acute exacerbations of chronic obstructive pulmonary disease[ J]. Am J Health Syst Pharm ,2006, 63 (7) :645-652.
  • 10Vondmcek SF,Hemstroet BA. Is there an optimal cortieosteroid regi- men for the management of an acute exacerbation of chronic obstruc- tive pulmonary disease? [J]. Pharmacotherapy,2006,26(4) :522-532.

同被引文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部